Panacea Biotec Limited — Important, 28-12-2024: General Updates

Panacea Biotec Pharma Limited (PBPL), a subsidiary of Panacea Biotec Ltd, has made a significant further investment of US$ 9,25,000 (~Rs. 7.92 Crore) in its wholly-owned subsidiary, Panacea Biotec Inc. This investment is intended for the acquisition of 9.25 crore shares of common stock at US$ 0.01 per share. The newly established PB Inc. aims to tap into the US healthcare market, engaging in activities including marketing and distributing health-related products such as OTC drugs and vaccines. PBPL will retain 100% ownership in PB Inc., positioning the company for potential growth in a lucrative industry. This development reflects a positive outlook, as the subsidiary’s strategic focus aligns with broader company goals in the healthcare sector. Investors may watch closely for further updates and the execution of business plans as PB Inc. progresses.